Cargando…
Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
Advances in immunotherapy have achieved remarkable clinical outcomes in tumors with low curability, but their effects are limited, and increasing evidence has implicated tumoral and non-tumoral components of the tumor microenvironment as critical mediators of cancer progression. At the same time, th...
Autores principales: | Benavente, Sergi, Sánchez-García, Almudena, Naches, Silvia, LLeonart, Matilde Esther, Lorente, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645077/ https://www.ncbi.nlm.nih.gov/pubmed/33194719 http://dx.doi.org/10.3389/fonc.2020.582884 |
Ejemplares similares
-
Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021) -
The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021) -
Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021) -
Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021) -
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
por: Czajka-Francuz, Paulina, et al.
Publicado: (2023)